Awiqli, Novo Nordisk’s long-acting weekly insulin injection, has been approved for adults with type 2 diabetes — offering a simpler dosing schedule that could improve daily blood sugar control and quality of life.
🔗
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-novos-insulin-injection-type-2-diabetes-2026-03-26/
#Study #Nutrition 🌿
